MR PREDICTS Decision Tool and Validation in Acute Ischemic Stroke

The HERMES collaborators and MR CLEAN Registry Investigators examined data from 6 randomized controlled trials, amounting to 4398 patients. Patients with low (<1%) predicted treatment benefit (n=135/3156 [4.3%]) had low rates of functional independence, irrespective of reperfusion status, suggesting potential absence of treatment benefit. This model was made available to researchers and clinicians at www.mrpredicts.com. Although this may help in determining and predicting likelihood of good outcomes, this is another tool in the arsenal of managing acute ischemic stroke patients.

Check out the full article here.